Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Vera Therapeutics Inc Is A Clinical Stage Biotechnology Company. It Is Focused On Developing And Commercializing Transformative Treatments For Patients With Serious Immunological Diseases. The Company'S Product Candidate Is Atacicept, A Fusion Protein Self-Administered As A Subcutaneous Injection Once Weekly That Blocks Both B Lymphocyte Stimulator And A Proliferation-Inducing Ligand, Which Stimulate B Cells And Plasma Cells To Produce Autoantibodies Contributing To Certain Autoimmune Diseases.